Healthcare and Pharmaceuticals industry

Global Small Molecule Prefilled Syringes Market Size Share Forecast 2024




 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Prefilled syringes are specialized formulation consisting of either small molecules or large molecules. The final costs of these products are a combination of the price of drug formulation as well as syringe component. Significant amount of research and development is necessary to bring these products in the market, which results in prices being higher, as specialized drug delivery systems are utilized. In some countries such as the U.S., Canada, and Australia, the medicinal products that are sold in prefilled syringes are termed as combination products. Regulatory scenario for the combination products has been properly defined in the U.S. and Canada. However, in other regions such as Europe and Asia Pacific the regulations for combination products have not been properly defined. U.S. FDA regulates these products as combination products.
Market Dynamics
Major drugs in the neurology drugs segment such as Copaxone (manufactured by Teva Pharmaceutical Industries Ltd.) are expected to face competition from generics. Manufacturers such as Schott AG are involved in prefilled syringe product innovation, in order to improve medical outcomes, which compliments growth of the small molecule prefilled syringe market. The market is expected to exhibit significant growth, owing to increasing adoption of technologically advanced prefilled syringes such as Schott TopPac. Advantages offered by prefilled syringes such as accurate dosage, and instant therapeutic effect over conventional products such as tablets and capsules is expected to foster growth of small molecule prefilled syringes market.
Key features of the study:
• This report provides in-depth analysis of small molecule prefilled syringes market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2017-2025), considering 2016 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
• It profiles leading players in the global small molecule prefilled syringes market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key companies covered as a part of this study include Pfizer, Inc., Sanofi S.A., Mylan N.V., Teva Pharmaceutical Industries Ltd., Becton, Dickinson and Company, and Fresenius Kabi AG
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
• The global small molecule prefilled syringes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the small molecule prefilled syringes market
Detailed Segmentation:
• Global Small Molecule Prefilled Syringes Market, by Drug Class:
o Cardiovascular Drugs
o Neurology Drugs
o Analgesics
o Adjuvants
o Others
• Global Small Molecule Prefilled Syringes Market, by Material Type:
o Glass
o Plastic & Polymer
• Global Small Molecule Prefilled Syringes Market, by Region:
o North America
 By Drug Class:
 Cardiovascular Drugs
 Neurology Drugs
 Analgesics
 Adjuvants
 Others
 By Material Type:
 Glass
 Plastic & Polymer
 By Country:
 U.S.
 Canada
o Europe
 By Drug Class:
 Cardiovascular Drugs
 Neurology Drugs
 Analgesics
 Adjuvants
 Others
 By Material Type:
 Glass
 Plastic & Polymer
 By Country:
 U.K.
 Germany
 Italy
 France
 Spain
 Russia
 Rest of Europe
o Asia Pacific
 By Drug Class:
 Cardiovascular Drugs
 Neurology Drugs
 Analgesics
 Adjuvants
 Others
 By Material Type:
 Glass
 Plastic & Polymer
 By Country:
 China
 India
 Japan
 ASEAN
 Australia
 South Korea
 Rest of Asia Pacific
o Latin America
 By Drug Class:
 Cardiovascular Drugs
 Neurology Drugs
 Analgesics
 Adjuvants
 Others
 By Material Type:
 Glass
 Plastic & Polymer
 By Country:
 Brazil
 Mexico
 Rest of Latin America
o Middle East
 By Drug Class:
 Cardiovascular Drugs
 Neurology Drugs
 Analgesics
 Adjuvants
 Others
 By Material Type:
 Glass
 Plastic & Polymer
 By Country:
 GCC
 Israel
 Rest of Middle East
o Africa
 By Drug Class:
 Cardiovascular Drugs
 Neurology Drugs
 Analgesics
 Adjuvants
 Others
 By Material Type:
 Glass
 Plastic & Polymer
 By Country:
 Central Africa
 South Africa
 North Africa
• Company Profiles
o Pfizer, Inc.*
 Company Overview
 Product Portfolio
 Financial Performance
 Key Strategies
 Recent Developments
o Sanofi S.A.
o Mylan N.V.
o Teva Pharmaceutical Industries Ltd.
o Becton, Dickinson, and Company
o Fresenius Kabi AG
"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
? Market Definition and Scope
o Executive Summary
? Market Snippet, By Drug Class
? Market Snippet, By Material Type
? Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
? Drivers
? Restraints
? Market Opportunities
o Impact Analysis
o PEST Analysis
o PORTER's Analysis
o Regulatory Scenario
4. Global Small Molecule Prefilled Syringes Market, By Drug Class, 2015-2025 (US$ Mn)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, 2016-2025
? Segment Trends
o Cardiovascular Drugs
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
o Neurology Drugs
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
o Analgesics
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
o Adjuvants
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
o Others
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
5. Global Small Molecule Prefilled Syringes Market, By Material Type, 2015-2025 (US$ Mn)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, 2016-2025
? Segment Trends
o Glass
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
o Plastic & Polymer
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
6. Global Small Molecule Prefilled Syringes Market, By Regions, 2015-2025 (US$ Mn)
o Introduction
? Market Share Analysis, By Region, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, For Regions, 2016-2025
? Regional Trends
o North America
? Market Size and Forecast, By Drug Class, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Material Type, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2015-2025 (US$ Mn)
? U.S.
? Canada
o Europe
? Market Size and Forecast, By Drug Class, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Material Type, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2015-2025 (US$ Mn)
? U.K.
? Germany
? Italy
? France
? Spain
? Russia
? Rest of Europe
o Asia Pacific
? Market Size and Forecast, By Drug Class, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Material Type, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2015-2025 (US$ Mn)
? China
? India
? Japan
? ASEAN
? Australia
? South Korea
? Rest of APAC
o Latin America
? Market Size and Forecast, By Drug Class, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Material Type, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2015-2025 (US$ Mn)
? Brazil
? Mexico
? Argentina
? Rest of Latin America
o Africa
? Market Size and Forecast, By Drug Class, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Material Type, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2015-2025 (US$ Mn)
? Central Africa
? South Africa
? North Africa
o Middle East
? Market Size and Forecast, By Drug Class, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Material Type, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2015-2025 (US$ Mn)
? GCC
? Israel
? Rest of Middle East
7. Competitive Landscape
o Company Profiles
? Pfizer, Inc.
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Sanofi S.A.
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Mylan N.V.
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Teva Pharmaceutical Industries Ltd.
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Becton, Dickinson, and Company
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Fresenius Kabi AG
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
8. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 34 market data tables and 55 figures on "Small Molecule Prefilled Syringes Market - Global forecast to 2025".

 



Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.